AI Summary
✦ ClarthaPrice Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 29 analysts
Fundamentals
Fundamentals institutional score is 96 using growth durability 96.2.
Valuation
Valuation institutional score is 19 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 47 using mean target upside 8.3%; dispersion penalty 20.4; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 48 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is balanced or not decisive enough to tilt the tape. Based on 12 recent ticker-linked news items.
Signal Summary
Market intelligence remains Neutral. fundamentals provide support, while valuation and analyst consensus remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 57.9% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +2.07). Confidence: 76%.
Live forward EPS implies next-12-month EPS of ₹109.94. Applying the stock's normalized valuation corridor produces a fair range of ₹887.22 to ₹1,197.25, with base value near ₹991.66 (-5.5% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹109.94
Forward P/E
9.5x
Base Fair Value
₹991.66
Fair Range
₹887.22 - ₹1,197.25
Upside To Base
-5.5%
Estimate Source
Live forward EPS
Growth Estimate
+75.1%
5Y Average
8.25
Current
14.24
Overvalued
10.89
Undervalued
8.07
5Y Average
4.34
Current
7.49
Overvalued
4.90
Undervalued
3.22
5Y Average
1.43
Current
1.71
Overvalued
1.65
Undervalued
1.22
Peers & Comparison
Sector: Materials · Theme: Metals - Aluminium
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
GRASIM INDUSTRIES LTD GRASIMCement | +10.5% | 2.8% | 45.5x Fair | -7% vs avg | +23.4% |
HCL TECHNOLOGIES LTD HCLTECHIT Services & Consulting | +3.0% | 13.0% | 21.2x Undervalued | -57% vs avg | -8.8% |
DR. REDDY S LABORATORIES DRREDDYPharmaceuticals | -5.6% | 10.0% | 30.7x Undervalued | -37% vs avg | -5.0% |
CG POWER AND IND SOL LTD CGPOWERHeavy Electrical Equipments | +14.0% | 9.8% | 111.4x Premium | +128% vs avg | +32.2% |
BAJAJ AUTO LIMITED BAJAJ-AUTOTwo Wheelers | +64.0% | 16.3% | 27.8x Undervalued | -43% vs avg | +42.5% |
EICHER MOTORS LTD EICHERMOTTrucks & Buses | +31.5% | 23.2% | 38.1x Undervalued | -22% vs avg | +41.7% |
APOLLO HOSPITALS ENTER. L APOLLOHOSPHospitals & Diagnostic Centres | +18.1% | 7.7% | 65.1x Premium | +33% vs avg | +23.2% |
BSE LIMITED BSEStock Exchanges & Ratings | +64.0% | 48.9% | 50.4x Fair | +3% vs avg | +50.1% |
HINDALCO INDUSTRIES LTD trades at a discount (14.3x vs peer avg 48.8x), suggesting potential undervaluation relative to the Metals - Aluminium cohort. Peers include GRASIM INDUSTRIES LTD, HCL TECHNOLOGIES LTD, DR. REDDY S LABORATORIES — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹30.52K CrJun 2026Latest net profit
₹4.78K CrJun 2026Latest EPS
₹21.29Jun 2026Net margin
23.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 19,904 | 20,676 | 20,289 | 22,140 | 22,155 | 22,262 | 23,776 | 25,116 | 24,264 | 24,780 | 29,264 | 34,244 | 30,515 |
| Expenses + | 18,343 | 18,920 | 18,326 | 19,920 | 19,406 | 19,513 | 21,112 | 22,117 | 21,126 | 21,040 | 25,016 | 29,098 | 23,530 |
| Operating Profit | 1,561 | 1,756 | 1,963 | 2,220 | 2,749 | 2,749 | 2,664 | 2,999 | 3,138 | 3,740 | 4,248 | 5,146 | 6,985 |
| OPM % | 8% | 8% | 10% | 10% | 12% | 12% | 11% | 12% | 13% | 15% | 15% | 15% | 23% |
| Other Income + | 213 | 199 | 133 | 179 | 155 | 825 | 140 | 209 | 313 | 250 | 322 | 267 | 345 |
| Interest | 352 | 338 | 317 | 261 | 244 | 234 | 226 | 235 | 185 | 174 | 252 | 275 | 285 |
| Depreciation | 482 | 489 | 483 | 507 | 499 | 492 | 514 | 524 | 542 | 564 | 575 | 626 | 626 |
| Profit before tax | 940 | 1,128 | 1,296 | 1,631 | 2,161 | 2,848 | 2,064 | 2,449 | 2,724 | 3,252 | 3,743 | 4,512 | 6,419 |
| Tax % | 36% | 25% | 35% | 13% | 32% | 34% | 29% | 36% | 32% | 30% | 19% | 35% | 25% |
| Net Profit + | 600 | 847 | 838 | 1,412 | 1,471 | 1,891 | 1,463 | 1,561 | 1,862 | 2,266 | 3,017 | 2,934 | 4,784 |
| EPS in Rs | 2.67 | 3.77 | 3.73 | 6.28 | 6.55 | 8.41 | 6.51 | 6.95 | 8.29 | 10.08 | 13.43 | 13.06 | 21.29 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome